A prospective study on the use of mycophenolate mofetil in children with cyclosporine-dependent nephrotic syndrome
- 4 November 2006
- journal article
- clinical trial
- Published by Springer Science and Business Media LLC in Pediatric Nephrology
- Vol. 22 (1), 71-76
- https://doi.org/10.1007/s00467-006-0294-0
Abstract
Cyclosporine A (CsA) has relieved children with steroid-dependent nephrotic syndrome (NS) from steroid toxicity. However, most patients frequently relapse again when CsA is withdrawn, resulting in the development of CsA nephropathy for its long-term use. In order to assess the efficacy of mycophenolate mofetil (MMF) therapy, we prospectively analyzed 12 children with idiopathic steroid-dependent NS requiring long-term CsA therapy with MMF for at least 6 months. Mean follow-up after starting MMF was 11 months (range 6–42). The mean MMF dose required was 610±95 mg/m2/12 h, which maintained mean predose mycophenolic acid (C0-MPA) levels of 2.4±1.1 mcg/ml. Treatment with MMF resulted in CsA and/or prednisolone (PSL) sparing, with a reduction in mean CsA dose from 3.5±1.3 to 1.5±2.4 mg/kg/day (p<0.01), and mean PSL dose from 0.29±0.16 to 0.21±0.11 mg/kg/day (p<0.05). Nine of 12 patients (75%) were finally able to be weaned off CsA. Mean relapse rates decreased from 2.7±1.6 to 0.6±0.9 episodes/year (p<0.01). Relapse-free ratio on MMF therapy was lower in patients whose average C0-MPA levels were less than 2 mcg/ml (p<0.05). Our experience demonstrates that MMF therapy results in significant CsA and/or steroid sparing and reduction in relapse rates in children with CsA-dependent NS.Keywords
This publication has 24 references indexed in Scilit:
- Independent risk factors for chronic cyclosporine induced nephropathy in children with nephrotic syndromeArchives of Disease in Childhood, 2006
- Short-term outcomes of severe lupus nephritis in a cohort of predominantly African–American childrenPediatric Nephrology, 2006
- High-dose mizoribine therapy for childhood-onset frequently relapsing steroid-dependent nephrotic syndrome with cyclosporin nephrotoxicityPediatric Nephrology, 2005
- Mycophenolate mofetil therapy in frequently relapsing steroid-dependent and steroid-resistant nephrotic syndrome of childhood: current status and future directionsPediatric Nephrology, 2005
- Efficacy of mycophenolate mofetil in pediatric patients with steroid-dependent nephrotic syndromePediatric Nephrology, 2005
- Mycophenolate mofetil in steroid/cyclosporine-dependent/resistant nephrotic syndromePediatric Nephrology, 2005
- Switch from cyclosporine A to mycophenolate mofetil in nephrotic childrenPediatric Nephrology, 2005
- Use of mycophenolate mofetil in steroid-dependent and -resistant nephrotic syndromePediatric Nephrology, 2003
- Cyclophosphamide does not benefit patients with focal segmental glomerulosclerosisPediatric Nephrology, 1996
- Early identification of frequent relapsers among children with minimal change nephrotic syndrome: A report of the International Study of Kidney Disease in ChildrenThe Journal of Pediatrics, 1982